Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Alcaligenes faecalis | 1 | 2017 | 2 | 0.71 | Why? |
Community Health Centers | 1 | 2020 | 201 | 0.68 | Why? |
Arabidopsis | 1 | 2017 | 88 | 0.65 | Why? |
Syncope | 1 | 2018 | 238 | 0.57 | Why? |
Volatile Organic Compounds | 1 | 2017 | 187 | 0.56 | Why? |
Shock, Cardiogenic | 1 | 2020 | 700 | 0.51 | Why? |
Percutaneous Coronary Intervention | 1 | 2020 | 3646 | 0.25 | Why? |
Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
Glucose Transporter Type 3 | 1 | 2019 | 7 | 0.20 | Why? |
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2020 | 58 | 0.20 | Why? |
Cyclohexanones | 1 | 2018 | 9 | 0.19 | Why? |
Pulmonary Embolism | 1 | 2018 | 4775 | 0.18 | Why? |
Gibberellins | 1 | 2017 | 4 | 0.18 | Why? |
Indoleacetic Acids | 1 | 2017 | 13 | 0.17 | Why? |
Republic of Korea | 5 | 2021 | 5858 | 0.17 | Why? |
Gene Expression Regulation, Plant | 1 | 2017 | 110 | 0.16 | Why? |
Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.14 | Why? |
Electrochemical Techniques | 1 | 2018 | 406 | 0.14 | Why? |
Inhalation Exposure | 1 | 2018 | 405 | 0.13 | Why? |
Patient Transfer | 1 | 2020 | 898 | 0.12 | Why? |
Troponin I | 1 | 2018 | 1298 | 0.10 | Why? |
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 896 | 0.10 | Why? |
Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
Prognosis | 6 | 2021 | 32490 | 0.08 | Why? |
Electrocardiography | 1 | 2020 | 3957 | 0.08 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 5277 | 0.07 | Why? |
Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.07 | Why? |
Length of Stay | 2 | 2020 | 11042 | 0.07 | Why? |
Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
Extracorporeal Membrane Oxygenation | 2 | 2021 | 5002 | 0.07 | Why? |
Biosensing Techniques | 1 | 2018 | 2116 | 0.07 | Why? |
Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
Myocardial Infarction | 1 | 2020 | 3361 | 0.07 | Why? |
Kidney | 1 | 2018 | 3648 | 0.07 | Why? |
Liver | 1 | 2018 | 4007 | 0.07 | Why? |
Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
Middle Aged | 8 | 2021 | 270681 | 0.06 | Why? |
Occupational Health | 1 | 2018 | 3965 | 0.06 | Why? |
Lung Neoplasms | 1 | 2019 | 3228 | 0.06 | Why? |
Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
Male | 10 | 2021 | 367725 | 0.05 | Why? |
Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
Drosophila Proteins | 1 | 2021 | 67 | 0.05 | Why? |
Coronavirus | 2 | 2020 | 18339 | 0.05 | Why? |
Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
No-Observed-Adverse-Effect Level | 1 | 2018 | 15 | 0.05 | Why? |
Rats, Inbred F344 | 1 | 2018 | 33 | 0.05 | Why? |
Lymphocytosis | 1 | 2020 | 122 | 0.05 | Why? |
Mice, Inbred Strains | 1 | 2018 | 136 | 0.05 | Why? |
Toxicity Tests | 1 | 2018 | 100 | 0.05 | Why? |
Multivariate Analysis | 2 | 2020 | 5440 | 0.05 | Why? |
APACHE | 1 | 2021 | 682 | 0.05 | Why? |
Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
Female | 9 | 2021 | 380317 | 0.04 | Why? |
Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
ErbB Receptors | 1 | 2019 | 320 | 0.04 | Why? |
Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
Kidney Function Tests | 1 | 2018 | 520 | 0.04 | Why? |
Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
Aged | 7 | 2021 | 215776 | 0.04 | Why? |
Pandemics | 8 | 2020 | 389249 | 0.04 | Why? |
Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
Aptamers, Nucleotide | 1 | 2018 | 265 | 0.04 | Why? |
Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
Humans | 12 | 2021 | 930598 | 0.04 | Why? |
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.04 | Why? |
Graphite | 1 | 2018 | 318 | 0.04 | Why? |
Gold | 1 | 2018 | 592 | 0.03 | Why? |
Organ Specificity | 1 | 2018 | 1070 | 0.03 | Why? |
Alanine Transaminase | 1 | 2020 | 1329 | 0.03 | Why? |
C-Reactive Protein | 2 | 2020 | 7972 | 0.03 | Why? |
Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.03 | Why? |
Liver Function Tests | 1 | 2018 | 1325 | 0.03 | Why? |
Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
Metal Nanoparticles | 1 | 2018 | 771 | 0.03 | Why? |
Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
Limit of Detection | 1 | 2018 | 2698 | 0.03 | Why? |
Membrane Proteins | 1 | 2021 | 1733 | 0.03 | Why? |
Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
Adult | 3 | 2020 | 244371 | 0.02 | Why? |
Severity of Illness Index | 3 | 2020 | 48226 | 0.02 | Why? |
Thrombocytopenia | 1 | 2020 | 2093 | 0.02 | Why? |
Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
Blood Glucose | 1 | 2020 | 3642 | 0.02 | Why? |
Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
Respiration, Artificial | 2 | 2021 | 22116 | 0.02 | Why? |
Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_